Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
expert perspectives defining and managing progressive pulmonary fibrosis in systemic sclerosis
Original title: “Expert Perspectives: Defining and managing progressive pulmonary fibrosis in systemic sclerosis.”
novel hla class i and ii insights into the pathogenesis of systemic sclerosis associated interstitial lung disease
Original title: “Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung disease.”
clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis
Original title: “The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.”
systemic sclerosis in children and older juvenile onset patients real life map by the egyptian college of rheumatology
Original title: “Systemic sclerosis in children and older juvenile-onset patients: real-life map by the Egyptian college of Rheumatology.”
rituximab associated colitis with colonic perforation requiring subtotal colectomy in systemic sclerosis
Original title: “Rituximab-associated colitis with colonic perforation requiring subtotal colectomy in systemic sclerosis.”
novel stratification framework based on vascular fibrotic complications identifies distinct risk endotypes in systemic sclerosis a retrospective cohort study
Original title: “A novel stratification framework based on vascular-fibrotic complications identifies distinct risk endotypes in systemic sclerosis: a retrospective cohort study.”
clinical and serological features of triple autoantibody negative patients with systemic sclerosis insights from the multicentric spring registry of the italian society for rheumatology
Original title: “Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.”
scoping literature review on applied definitions of very early diagnosis of systemic sclerosis vedoss and pre systemic sclerosis in original articles
Original title: “Scoping literature review on applied definitions of very early diagnosis of systemic sclerosis (VEDOSS) and pre-systemic sclerosis in original articles.”
factors associated with variations in the 6 minute walk distance during the follow up of patients with systemic sclerosis
Original title: “Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosis.”
environmental and occupational factors in the aetiopathogenesis of systemic sclerosis insights from a large multinational patient survey
Original title: “Environmental and occupational factors in the aetiopathogenesis of systemic sclerosis: insights from a large multinational patient survey.”
retrospective analysis of clinical characteristics of systemic sclerosis associated interstitial lung disease
Original title: “A retrospective analysis of clinical characteristics of systemic sclerosis-associated interstitial lung disease.”
combination therapy with mycophenolate mofetil nintedanib and tocilizumab in a patient with progressive systemic sclerosis associated interstitial lung disease a case report and a literature review
Original title: “Combination therapy with mycophenolate mofetil, nintedanib, and tocilizumab in a patient with progressive systemic sclerosis-associated interstitial lung disease : A case report and a literature review.”
Company targets new approach to treating rheumatoid arthritis and systemic sclerosis
Original title: “Quell launches chill phase 1/2 trial for novel cartreg therapy”
biologic rescue with tocilizumab a case of refractory chronic pericardial effusion in systemic sclerosis
Original title: “Biologic Rescue With Tocilizumab: A Case of Refractory Chronic Pericardial Effusion in Systemic Sclerosis.”
longitudinal assessment of the juvenile systemic sclerosis severity score application in the national registry for childhood onset scleroderma
Original title: “Longitudinal Assessment of the Juvenile Systemic Sclerosis Severity Score: Application in the National Registry for Childhood Onset Scleroderma.”
multifaceted role of platelets in systemic sclerosis beyond haemostasis
Original title: “The multifaceted role of platelets in systemic sclerosis: beyond haemostasis!”
drug development in systemic sclerosis novel therapeutics to watch
Original title: “Drug development in systemic sclerosis: novel therapeutics to watch.”
management of pulmonary arterial hypertension in systemic sclerosis from classical treatments to new horizons
Original title: “Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons.”
cytometry based blood immune cell markers associated with clinical outcomes in systemic sclerosis protocol for a systematic review
Original title: “Cytometry-based blood immune cell markers associated with clinical outcomes in systemic sclerosis: protocol for a systematic review.”
advancing drug development for systemic sclerosis by prioritising findings from human genetic association studies
Original title: “Advancing drug development for systemic sclerosis by prioritising findings from human genetic association studies.”